Herpes Zoster
📧 Sign up to get email alerts when something new happens for Herpes Zoster.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2009-12-07FDA Approved: ACYCLOVIR — Supplemental Application (Aurobindo Pharma Limited)
FDA approves a supplemental application for acyclovir from Aurobindo Pharma Limited.
-
CLINICAL_TRIALS trial_result · 2009-07-03Clinical Trial Update: A Study to Evaluate Safety, Tolerability, and Immunogenicity of an Investigational Zoster Vaccine In Subjects With a History of Varicella (Chickenpox)(V211-010)(COMPLETED) [Phase 3]
A Phase 3 trial completed to assess safety, tolerability, and immunogenicity of an investigational zoster vaccine in adults with a history o…
-
CLINICAL_TRIALS trial_result · 2009-05-13Clinical Trial Update: ZOSTAVAX™ Administered Concomitantly With PNEUMOVAX™ 23 (V211-012)(COMPLETED) [Phase 3]
A Phase 3 trial evaluated concomitant administration of ZOSTAVAX with PNEUMOVAX 23; the study is completed and results were posted in 2009.
-
FDA approval · 2009-04-29FDA Approved: FAMCICLOVIR — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
The FDA approved a Teva Pharmaceuticals supplemental application for famciclovir, resulting in an updated indication/label for the generic a…
-
CLINICAL_TRIALS trial_result · 2009-04-23Clinical Trial Update: The Effect of Pharmacist Intervention on the Use of Zostavax in a Community Pharmacy Setting [NA]
This completed study evaluated how pharmacist interventions affected use of the shingles vaccine Zostavax in a community pharmacy setting.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2008-10-07Clinical Trial Update: Study to Compare Efficacy of Topical ARYS-01 (Sorivudine) Cream 3%, Oral Valaciclovir and Combination ARYS-01 Cream 3%/Oral Valaciclovir for Treatment of Herpes Zoster (Shingles) [Phase 2]
Phase 2 trial evaluating ARYS-01 cream 3% (sorivudine), oral valaciclovir, and their combination for treatment of herpes zoster and preventi…
-
CLINICAL_TRIALS trial_result · 2008-07-22Clinical Trial Update: A 2 Week Study of Topical KD7040 in the Treatment of Postherpetic Neuralgia (PHN) [Phase 2]
A Phase 2 clinical trial evaluated topical KD7040 for postherpetic neuralgia and has completed. The update does not include efficacy or safe…
-
CLINICAL_TRIALS trial_result · 2008-06-03Clinical Trial Update: Activation of Alternative Cellular Energy (ACE) Pathway in the Therapy of Herpes Virus Infections
The clinical trial update indicates completion of a study evaluating the Activation of Alternative Cellular Energy (ACE) Pathway as a therap…
-
CLINICAL_TRIALS trial_result · 2008-03-06Clinical Trial Update: NGX-4010 for the Treatment of Postherpetic Neuralgia [Phase 2, Phase 3]
Phase 2 and Phase 3 trials of NGX-4010 (capsaicin patch 8%) for postherpetic neuralgia have completed, with status indicating completion of …
-
CLINICAL_TRIALS trial_result · 2008-03-06Clinical Trial Update: Study of NGX-4010 for the Treatment of Painful HIV-Associated Neuropathy (HIV-AN) or Postherpetic Neuralgia (PHN) [Phase 2]
A Phase 2 study evaluating NGX-4010 for painful HIV-associated neuropathy and postherpetic neuralgia has completed.
-
CLINICAL_TRIALS trial_result · 2008-03-04Clinical Trial Update: Dextromethorphan Versus Placebo for Neuropathic Pain [Phase 2]
A Phase 2 randomized trial comparing dextromethorphan to placebo for neuropathic pain in diabetic neuropathy, herpes zoster, and neuralgia w…
-
CLINICAL_TRIALS trial_result · 2008-01-11Clinical Trial Update: Tolerability of Three Local Anesthetic Formulations in Conjunction With NGX-4010 for the Treatment of Neuropathic Pain [Phase 2]
A Phase 2 trial update reports tolerability findings for three local anesthetic formulations used with NGX-4010 (capsaicin 8% patch) in the …
-
CLINICAL_TRIALS trial_result · 2007-12-21Clinical Trial Update: Long-Term Oral Acyclovir Usage to Prevent Herpes Zoster Virus Infection After Bone Marrow Transplant [Phase 3]
Phase 3 trial evaluating long-term oral acyclovir to prevent Varicella Zoster Virus infection after bone marrow transplantation; the study h…
-
FDA approval · 2007-12-11FDA Approved: VALTREX — Supplemental Application (GlaxoSmithKline LLC)
The FDA approved a supplemental application for Valtrex (valacyclovir hydrochloride) submitted by GlaxoSmithKline LLC, authorizing changes t…
-
CLINICAL_TRIALS trial_result · 2007-09-26Clinical Trial Update: Famciclovir Oral Pediatric Formulation in Children 1-12 Years of Age With Varicella Zoster Infection [Phase 3]
This update reports the completion of a Phase 3 trial evaluating the oral pediatric formulation of famciclovir in children aged 1-12 years w…
-
FDA approval · 2007-08-24FDA Approved: FAMCICLOVIR — Original Application (Teva Pharmaceuticals USA, Inc.)
FDA approved Teva's generic famciclovir (Original Application). This approval expands access to an antiviral for the treatment of herpes zos…
-
CLINICAL_TRIALS trial_result · 2007-05-24Clinical Trial Update: Randomized Study of Two Doses of Oral Valacyclovir in Immunocompromised Patients With Uncomplicated Herpes Zoster [NA]
A completed randomized trial compared two oral doses of valacyclovir in immunocompromised patients with uncomplicated herpes zoster.
-
FDA approval · 2007-01-31FDA Approved: VALACYCLOVIR — Original Application (SUN PHARMACEUTICAL INDUSTRIES, INC.)
FDA approved Sun Pharmaceutical Industries' original-application generic valacyclovir (valacyclovir), authorizing its marketing as an antivi…